Biotechnology Jobs

• Reading
• Remote
• Lead

Provides strategic medical and scientific subject matter expertise in hematology-oncology, advising internal stakeholders on protocol design, clinical development plans and proposals, and supporting client bid-defense meetings. Acts as an internal and external consultant across the research and development lifecycle, coaching project teams and collaborating with business development and operations. Greater independence is expected over time under the therapeutic area head.

• Warsaw, Poland
• On-site
• US$284,250 – US$473,750 pa
• Director

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and contributes to business development diligence.

Real World Evidence (RWE)

• London
• On-site
• US$284,250 – US$473,750 pa
• Director

Leads clinical development of oncology assets in genitourinary cancers, overseeing Phase 1-3 interventional trials from protocol design through final study report. Provides real-time medical monitoring, safety review with pharmacovigilance, and regulatory document authoring, while building relationships with key external experts. Serves as a core member of the Clinical Matrix Team and contributes to disease area strategy and business development diligence.

• London
• Hybrid
• Director · manages people

Leads global medical strategy for the Neurosciences portfolio, primarily Dysport Movement Disorders indications, defining evidence generation plans, registries and investigator-sponsored research. Acts as Medical functional lead on the global Asset Team, chairs the Medical & Evidence Generation Team, and represents Ipsen with KOLs, societies and advocacy groups. Also leads, coaches and develops Global Medical Directors across the organisation.

Dysport

• Cambridge
• Hybrid · 3 days in office
• Director · manages people

Owns International regulatory strategy for complex cell therapy programs, embedding regional requirements into evidence generation, submissions and labeling. Leads BLA/MAA planning, Health Authority engagements and labeling negotiations, integrating clinical, CMC, safety and commercial input. Also leads a matrix regulatory team, coaching colleagues and shaping policy and process improvements.

BLA · MAA · IND +2

• Uxbridge
• Hybrid · 3 days in office
• Director · manages people

Leads clinical development strategy for multiple myeloma cell therapy programs, overseeing trial design, conduct, reporting and regulatory submissions. Represents products in governance committees, provides medical monitoring, and manages a team of direct reports while building external thought-leader relationships.

Workday

• Uxbridge
• Director · manages people

Leads clinical strategy and execution for one or more GI oncology indications of a given asset, owning the Target Product Profile and disease area strategy. Manages a team of physicians and scientists designing, running, analysing and interpreting all clinical studies, and acts as internal and external clinical authority for regulatory interactions and business development. Requires deep therapeutic expertise and 8+ years of drug development experience, with international and domestic travel.

• Cambridge
• Hybrid · 3 days in office
• Director

Lead digital health strategy engagements with AstraZeneca R&D, top pharma and biotechs, shaping operating models and roadmaps across clinical development. Directs project teams on AI and digital solutions such as ePRO/eCOA, wearables and digital biomarkers, building business cases and tracking value realisation. Combines consulting, protocol design support and scaled implementation in a matrixed environment.

ePRO · eCOA · Wearables +1

• London
• Hybrid
• Lead · manages people

Leads one or more Early Development Asset Teams, owning integrated strategy from candidate nomination through first-in-human trials across preclinical, translational, clinical, regulatory and CMC workstreams. Serves as scientific champion for oncology assets, presenting data and investment recommendations to governance bodies and contributing to in-licensing due diligence.

• New York, United States
• Remote
• Senior · manages people

Leads clinical development strategy and execution across oncology and rare disease programs, overseeing early and late-stage trials, regulatory interactions, and biomarker-driven study design. Manages teams of clinical scientists and medical directors while embedding AI, machine learning, and real-world data into trial design and evidence generation.

Recursion OS

• Uxbridge
• Director

Serves as primary medical accountability for multiple Phase 1-3 clinical trials in GI oncology, leading medical data review, safety assessment and site interactions within a Study Delivery Team. Partners with Clinical Scientists on protocol design, benefit/risk analysis and health authority interactions, while building relationships with principal investigators and thought leaders.

• London
• Hybrid · 3 days in office
• Lead

Drive DMPK strategy across drug discovery projects, designing screening cascades and mechanistic experiments while integrating AI/ML and PBPK modelling to predict human dosing, efficacy and safety windows. Work within an interdisciplinary team of drug design and machine learning specialists, authoring regulatory documents and optimising molecule design with chemistry leads.

R · Python · KNIME

• New York, United States
• Hybrid
• US$321,800 – US$443,080 pa
• Director · manages people

Sets enterprise strategy for clinical pharmacology, pharmacometrics and model-informed drug development across a clinical portfolio, owning dose strategy from first-in-human through registrational development. Leads quantitative approaches including population PK, PK/PD, PBPK and QSP, represents the company in health authority interactions, and builds a high-performing function within an AI-native TechBio.

Recursion OS

• Stevenage
• Remote

Serves as the primary point of contact for Advanced Therapy Treatment Centres across South UK, driving appropriate utilisation of CAR T therapies and coordinating site qualification, setup and patient treatment logistics. Works cross-functionally with Marketing, Medical Affairs and Market Access, and is 80% field based with UK travel.

• United Kingdom
• Remote

Field-based commercial role owning relationships with Advanced Therapy Treatment Centres across the South UK, acting as the primary point of contact for CAR T therapy accounts. Responsibilities span site onboarding and qualification, coordinating patient treatment logistics and chain of identity, compliance audits, and strategic account planning with Marketing, Medical Affairs and Market Access. Requires deep haematology/oncology and cell therapy expertise, with around 80% travel.